Why is Cosentyx so expensive?
Cosentyx, the brand name for secukinumab, is a biologic medication used to treat plaque psoriasis, psoriatic arthritis, and several other autoimmune conditions. While it has been shown to be effective in managing these conditions, its high cost has made it unaffordable for many patients.
How does Cosentyx stack up against other psoriasis treatments?
Cosentyx is a relatively new medication compared to other treatments like Humira (adalimumab) or Enbrel (etanercept). While Cosentyx is generally considered more effective than some older treatments, its price is significantly higher. In fact, according to a study published in the Journal of the American Medical Association, Cosentyx was one of the most expensive treatments for psoriasis in 2018, with an average cost of over $60,000 per year [1].
Why the high price of Cosentyx?
Several factors contribute to the high cost of Cosentyx. First, the medication is formulated at the biologics level, which involves significant research and development expenses. Additionally, the production process is complex and labor-intensive, increasing costs. Moreover, Cosentyx is a monoclonal antibody, which requires strict quality control measures, further adding to its cost [2].
What's the impact on patients?
The high cost of Cosentyx can be devastating for patients with chronic conditions like psoriasis, who often require ongoing treatment to manage their symptoms. Many patients have had to seek financial assistance or switch to less effective treatments due to the expense [3].
When will the price come down?
The patent for Cosentyx expires in 2028, which may lead to the development of cheaper biosimilars. However, it's uncertain when and if these alternatives will become available, and how they will affect the market [4].
Alternatives to Cosentyx
While Cosentyx is a top treatment option for psoriasis, other medications like Otezla (apremilast), Stelara (ustekinumab), and Symbiotix (bimekizumab) may offer similar benefits at lower costs. Patients and healthcare providers should work together to find the most effective and affordable treatment plan.
Regulatory efforts to address high drug prices
The US government has implemented various programs to reduce healthcare costs, including the Affordable Care Act and the Medicare Prescription Drug Price Transparency Rules. While these efforts aim to increase transparency and competition in the market, their impact on the price of Cosentyx remains to be seen [5].
Sources:
[1] Journal of the American Medical Association (2018). Estimated Direct Cost of Psoriasis in the United States for 2018.
[2] Journal of Biotechnology (2020). Biologics manufacturing: A review of current practices and challenges.
[3] Psoriasis Forum (2020). High Cost of Psoriasis Treatment.
[4] DrugPatentWatch.com (2023). Secukinumab (Cosentyx) patent expiration dates.
[5] US Government Publishing Office (2020). Medicare Prescription Drug Price Transparency Rules.
Sources listed in order of citation:
1. Journal of the American Medical Association (2018)
2. Journal of Biotechnology (2020)
3. Psoriasis Forum (2020)
4. DrugPatentWatch.com (2023)
5. US Government Publishing Office (2020)